Craig’s Cause Pancreatic Cancer Society is a national non profit, charitable organization, which provides information, education and support to patients and caregivers. 100% of the funds donated support education, awareness and research grants. 

 

Calendar

Important Dates 



May 6th, 2014 ~ Support Group  ~ Rev. Maginley

June 7th, 2014 ~ Support Group  ~ Researcher

Sept. 2nd, 2014 ~ Support Group ~ Caregiver

Sept. 27th, 2014 ~ Pancreatic Cancer Awareness Walk/Run/Bike

Oct. 7th, 2014 ~ Support Group ~ Pharmacist

Nov. 4th, 2014 ~ Support Group

November 2014 ~ Pancreatic Cancer Awareness

Dec. 2nd, 2014 ~ Support Group

» View Calendar

 

Recent Video

Support Group Guest Speakers:

Dr. Scott Hurton on Pancreatic Cancer care research in Nova Scotia:

Debbie Matheson on being a caregiver:

Dr. Mark Walsh on Pancreatic Cancer "How are we doing and where are we going?"

Celine Burlock on how to find peace:

Roy Ellis talks about grief and loss:

Rob Rutledge talks about the mind-body-spirit connection:

Timothy Walker talks about Mindfulness Based Stress Reduction:

Dr. Colin MacLeod talks about naturopathic medicine and cancer:

Dr. Daniel Rayson talks about pancreatic cancer:

Reverend David McGinley talks about spirituality and cancer:

Wednesday
Jun012011

Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010

Several advances in genetics, diagnosis and palliation of pancreatic cancer (PC) have occurred in the last decades. A multidisciplinary approach to this disease is therefore recommended. PC is relatively common as it is the fourth leading cause of cancer related mortality. Most patients present with obstructive jaundice, epigastric or back pain, weight loss and anorexia. Despite improvements in diagnostic modalities, the majority of cases are still detected in advanced stages. The only curative treatment for PC remains surgical resection. No more than 20% of patients are candidates for surgery at the time of diagnosis and survival remains quite poor as adjuvant therapies are not very effective. A small percentage of patients with borderline non-resectable PC might benefit from neo-adjuvant chemoradiation therapy enabling them to undergo resection; however, randomized controlled studies are needed to prove the benefits of this strategy. Patients with unresectable PC benefit from palliative interventions such as biliary decompression and celiac plexus block. Further clinical trials to evaluate new chemo and radiation protocols as well as identification of genetic markers for PC are needed to improve the overall survival of patients affected by PC, as the current overall 5-year survival rate of patients affected by PC is still less than 5%.

The aim of this article is to review the most recent high quality literature on this topic.   

High Quality Literature Review on Pancreatic Cancer

« Pancreatic Cancer Support Group Meetings | Main | Deadliest cancers overlooked by charity donors: Study »